Cardiovascular and Endothelial Benefits GLP-1 RAs have demonstrated robust cardiovascular protection in multiple large-scale trials, including LEADER, REWIND, and SUSTAIN-6, showing reduced rates of major adverse cardiac events independent of weight loss
products may contain contaminants, adulterants, or unlisted substances Allergic reactions : Adhesive components and botanical extracts can cause contact dermatitis, skin irritation, or systemic allergic responses Drug interactions : Herbal ingredients may interact with prescription medications, including anticoagulants, antihypertensives, or diabetes medications False reassurance : Belief in patch efficacy may lead patients to neglect dietary modifications, physical activity, or medication adherence The financial burden represents another limitation
A GLP-1 Analog Liraglutide Reduces Intimal Hyperplasia After Coronary Stent Implantation via Regulation of Glycemic Variability and NLRP3 Inflammasome/IL-10 Signaling in Diabetic Swine
Who May Not Be a Good Candidate